Research Radartracking 85 published studies · 25 human · 14 clinical trials · 14 cancer pages · updated Jun 2026Open the Research Map →

Small Cell Carcinoma

Auto-discovered from research; not yet curated.

Auto-added · review pending
Educational only: This page is not medical advice. Coordinate decisions with your oncology team.

OncoForge editorial · How we review →

AI extractedhuman reviewedsources checkedretractions suppressed

Evidence at a glanceInsufficient evidenceInconclusive
1 published studies that name Small Cell Carcinoma0 human studies approved & graded (trial, observational, or meta-analysis)31 human clinical studies in the Small Cell Carcinoma corpus681 source documents in the Small Cell Carcinoma corpus
Why this grade?

Insufficient evidence — No primary experimental studies yet.

Computed deterministically from the studies’ types and reported outcomes — not written by AI, and not a claim that anything works.

What the guidelines say

NCI PDQESMONCCNASCO

We link the authoritative guidelines rather than reproduce them. Below, the treatments on this page are split by whether they’re guideline-backed standard of care or studied but not standard — so you can tell the established options from the experimental ones.

Read the guidelines

Cancer-specific deep links aren’t curated yet — these search the authoritative sources for Small Cell Carcinoma.

Get cited updates on Small Cell Carcinoma
A monthly email when the research changes — $10/mo. Manage follows
Follow Small Cell Carcinoma

What supports this page

The kinds of sources behind this page, strongest at the top. Faint rungs show what is not here yet.

Guideline
2
Meta-analysis
16
Systematic review
7
Randomized trial
1
Clinical trial
13
Observational
0
Case report
259
Review
383
Preclinical
0
Other
0

Living document — last change June 12, 2026: New cancer type added.

Overview

Small Cell Carcinoma is tracked here from the published studies that mention it. This page shows the research evidence collected so far — it is not a curated clinical overview.

What recent studies report in Small Cell Carcinoma

These are reviewed studies whose abstracts concern Small Cell Carcinoma. Each describes only what that study reported. This is not a claim by OncoForge that any compound helps or harms Small Cell Carcinoma. Most are early lab, animal, or small human studies, and findings often conflict.

1 study

Tracking 1 published study of Small Cell Carcinoma: 1 reviews/other.

Reported direction across studies: 1 inconclusive.

No human studies yet — these are preclinical (lab/animal) findings that may not translate to people.

These counts summarize what the studies reported; they are not a measure of whether anything works for Small Cell Carcinoma.

ReviewInconclusiveLimited evidenceTier 4 · clinical

Detailed overview on rare malignant ovarian tumors

Bulletin du cancer · Mar 2020 · narrative review

germ cell tumorssex cord-stromal ovarian tumorssmall cell carcinomamalignant Brenner tumorsmucinous carcinomaclear cell carcinomalow-grade serous carcinomaovarian carcinosarcoma

This is a narrative review summarizing pathology, clinical presentation, and treatment recommendations for a selection of rare malignant ovarian tumors. The authors state these tumors are heterogeneous, comprise about 10% of ovarian tumors, and that data and treatment recommendations are limited; they note that staging follows FIGO but treatment differs for germ cell and sex cord-stromal tumors. The review is based on recent national guidelines and related important publications.

Reported effect: Proportion of ovarian tumors 10%

Key findings
  • Rare malignant ovarian tumors covered include germ cell tumors, sex cord-stromal ovarian tumors, small cell carcinoma, malignant Brenner tumors, and rare epithelial tumors such as mucinous, clear cell and low-grade serous carcinomas, as well as ovarian carcinosarcoma.
  • Together these rare malignant ovarian tumors comprise about 10% of all ovarian tumors.
  • Because of low prevalence and heterogeneity, data and treatment recommendations for these tumors are limited.
  • Although all ovarian tumors are staged according to FIGO staging of epithelial ovarian tumors, treatment differs especially for germ cell tumors and sex cord-stromal ovarian tumors.
  • Non-epithelial ovarian tumors can arise from a variety of ovarian precursor cells such as germ cells, granulosa cells, theca cells, or stromal fibroblasts, reflecting divergent origins.
  • The article provides a comprehensive summary of pathology, clinical presentation, and therapy recommendations for a selection of rare ovarian tumors based on the latest national guidelines and important publications.
Limitations: Narrative review: methodology for literature selection is not specified in the abstract (not necessarily systematic).; No primary new data are reported in this article (summary of existing literature and guidelines).; Conclusions are limited by the low prevalence and substantial heterogeneity of the tumors discussed.; Therapeutic recommendations are constrained by limited evidence available for these rare tumor types..

AI summary of the abstract, human-reviewed · Jun 2026. Describes what this study reported, not medical advice. View on PubMed

Browse all studies mentioning Small Cell Carcinoma →

Clinical trials in Small Cell Carcinoma

Loading current trials from ClinicalTrials.gov… Search ClinicalTrials.gov →

Getting care & support

Nonprofit / Gov

Practical, vetted help for Small Cell Carcinoma — advocacy, paying for treatment, second opinions, and caregivers.

If you’re struggling emotionally, you don’t have to wait.

Advocacy & community

No dedicated organization for this specific cancer is curated yet — these general organizations can help in the meantime.

Financial help

  • PAN Foundation ↗ — Copay assistance funds by diagnosis (funds open and close as money allows). · status changes often — check the fund’s site
  • HealthWell Foundation ↗ — Copay and premium assistance funds by disease. · status changes often — check the fund’s site
  • CancerCare — financial assistance ↗ — Limited grants plus free financial counseling. · status changes often — check the fund’s site
  • Family Reach ↗ — Help with everyday living costs (rent, transport, food) during treatment. · status changes often — check the fund’s site
  • NeedyMeds ↗ — Searchable directory of drug patient-assistance and discount programs. · status changes often — check the fund’s site
What you’ll typically need to apply
  • Your diagnosis and, if you have it, the specific drug/treatment name (from your care team).
  • Insurance details — your member ID card, or a note that you're uninsured (some funds require active insurance, some don't).
  • Proof of income and household size (recent pay stubs, a tax return, or a benefits letter) — most funds are income-based.
  • Your prescriber's contact information; some programs need the clinic to submit part of the application.
  • Apply early and re-check: funds open and close as money is available, so a closed fund may reopen.

General guidance — each program sets its own eligibility. Confirm requirements on the program’s site.

Second opinions

Caregiver support

We list only non-profit and government resources — never product sellers — and take no affiliate fees. If a link is broken or a resource doesn't meet that bar, tell us.

Heading to an appointment? Get a printable one-page summary — studied compounds, open trials, interactions, and questions to ask.
Bring this to your appointment →